PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Adding Liriope Tuber (including L. spicata) to conventional medicine reduced PAF frequency, left atrium diameter, and P-wave dispersion [PMID:39247398]
Liriope spicata polysaccharides demonstrated in vitro hypoglycemic activities [PMID:28732860]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 38280236 (2024) — Quality variation of maidong (Ophiopogon japonicus and Liriope spicata) - A HPTLC-based approach. · Journal of pharmaceutical and biomedical analysis
- 2.PMID: 33584266 (2020) — A Novel Method to Identify Three Quality Grades of Herbal Medicine Ophiopogonis Radix by Microscopic Quantification. · Frontiers in pharmacology
- 3.PMID: 36291700 (2022) — Quality Evaluation of Ophiopogon japonicus from Two Authentic Geographical Origins in China Based on Physicochemical and Pharmacological Properties of Their Polysaccharides. · Biomolecules
- 4.PMID: 39366531 (2024) — Mechanism of DT-13 regulating macrophages in diabetic wound healing. · Cellular signalling
- 5.PMID: 41016234 (2026)